Summary

[lycralycra8 Users]

lycralycra8 Users

• 

Offline

Show Posts
Show Stats

Posts:

0 (0 per day)

Age:

N/A

Date Registered:

2025-07-12, 18:15:23

Local Time:

2025-07-19, 03:59:32

Last Active:

2025-07-12, 20:53:36

Signature:

OBJECTIVE Apatinib mesylate is a novel vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, which has exhibited good safety and efficacy